This site is intended for health professionals only

Published on 2 July 2007

Share this story:
Twitter
LinkedIn

European authorisation for schizophrenia drug

teaser

The European Commission has granted marketing authorisation for the atypical antipsychotic Invega



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn